Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Vijaya Diagnostic Centre announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations: Rs 1,732.4 million vs Rs 1,552.1 million during Q4FY24 (YoY change: 11.6%) EBITDA: Rs 688.6 million vs Rs 631.1 million during Q4FY24 (YoY change: 9.1%) EBITDA Margin: 39.8% vs 40.7% during Q4FY24 (change: -91 bps) Profit After Tax (PAT): Rs 346.4 million vs Rs 334.5 million during Q4FY24 (YoY change: 3.5%) PAT Margin: 20.0% vs 21.6% during Q4FY24 (change: -156 bps) FY25 Financial Highlights: Revenue from Operations: Rs 6,813.9 million vs Rs 5,478.1 million during Q4FY24 (YoY change: 24.4%) EBITDA: Rs 2,732.2 million vs Rs 2,209.0 million during Q4FY24 (YoY change: 23.7%) EBITDA Margin: 40.1% vs 40.3% during Q4FY24 (change: -23 bps) Profit After Tax (PAT): Rs 1,430.8 million vs Rs 1,188.3 million during Q4FY24 (YoY change: 20.4%) PAT Margin: 21.0% vs 21.7% during Q4FY24 (change: -69 bps) Suprita Reddy, MD & CEO, said: “Vijaya reported another strong financial year with YoY growth of 24.4% and an organic growth of 18.9%. I’m happy to announce the successful launch of 6 hubs in the last 2 months - 2 each in Pune, West Bengal and Bengaluru. Additionally, the execution of 3 more hubs in West Bengal is progressing as planned and is expected to be commercialized within the next 3 to 4 months. We have also finalized leases for two hubs in Tier-2 locations of AP & Telangana, which are scheduled to become operational in H2FY26. After a strong performance in FY25, we had a promising start to the new financial year, with a notable increase in both footfalls and revenue across our network. Moving forward, our key areas of focus would be stabilisation of the newly launched hubs and building strong brand equities in these new geographies, commissioning additional new hubs in West Bengal and Core geographies, investment in technology and strengthening our talent pool across critical departments.” Result PDF
Healthcare Services company Vijaya Diagnostic Centre announced Q3FY25 results Revenue from Operations: Rs 1,689.8 million compared to Rs 1,326.9 million during Q3FY24, change 27.3%. EBITDA: Rs 671.3 million compared to Rs 523.1 million during Q3FY24, change 28.3%. EBITDA margin: 39.7% for Q3FY25. PAT: Rs 351.6 million compared to Rs 258.5 million during Q3FY24, change 36.0%. PAT margin: 20.8% for Q3FY25. Suprita Reddy, MD & CEO said: “I’m pleased to announce another strong quarter, marked by a remarkable year-on-year revenue growth of 27.3%, with a solid 20.2% growth achieved organically. This strong performance was primarily driven by volume across both Pathology and Radiology segments. I am happy to share that we have operationalized our 1st centre at Pimple Saudagar, Pune (Spoke) under Vijaya PH Brand in this month, following the PH acquisition. Looking ahead, I am excited to announce that we would be commissioning 6 hubs across Pune, West Bengal and Bengaluru in the coming 3 months, taking our total hub addition to 9 in the 12-month period which marks a significant milestone in the history of Vijaya. We have also made key strategic hires at the mid and senior levels across functions to support the management in driving the next phase of growth.” Result PDF
Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Vijaya Diagnostic Centre announced Q2FY25 results Revenue from Operations: Rs 1,829.5 million compared to Rs 1,388.6 million during Q2FY24, change 31.8%. EBITDA: Rs 759.8 million compared to Rs 573.7 million during Q2FY24, change 32.5%. EBITDA Margin: 41.5% for Q2FY25. PAT: Rs 419.4 million compared to Rs 333.2 million during Q2FY24, change 26.9%. PAT margin: 22.9% for Q2FY25. Suprita Reddy, MD & CEO said: “I’m excited to announce another key milestone in our growth journey. We have delivered a robust quarter, achieving an impressive 31.8% YoY revenue growth, of which 23.0% was organic. This strong performance was driven primarily by volume, with contributions coming from both our existing and newly launched centres. I’m also delighted to share that we successfully launched operations at our Hub center in Ongole this August, and the response in the first two months has been very promising. In addition, we are excited to begin operations at our new state-of-the-art facility in Nizamabad tomorrow. This center features cuttingedge technologies, including a 3T MRI, CT scan, an automated lab, and a range of basic radiology modalities. We’ve also upgraded our spoke centre in Gurgaon, transforming it into a fully equipped hub with the addition of MRI and CT machines. This enhancement enables us to provide a complete range of services, from basic blood tests to advanced imaging, all conveniently available under one roof at our Gurgaon centre.” Result PDF